Screening Appointments Available!

Study Details

The investigational drug in this research study is being developed for the potential treatment of obesity and potentially type 1 and 2 diabetes mellitus. Tirzepatide is an injectable prescription drug that has been approved by the FDA for chronic weight management in doses up to 15 mg once weekly, in addition to diet, exercise, and oral medications. The use of tirzepatide in combination with the study drug in this study is investigational. 

Fortrea Dallas, TX is recruiting for:

-Healthy Men and Women of non-childbearing potential, age 18-65

-Body Mass Index between 27-40

-Study involves 1 stay of 6 nights at our clinic & 7 follow-up visits

-Compensation up to $8,708 may be provided for time and participation

-Refer a friend to receive $400 per qualified referral

Additional Details

C1:

Check-in: Jul 29

Check-out: Aug 4

Outpatient visits: Aug 6, 13, 20, 27, Sep 10, 24, Oct 8

OR

Check-in: Aug 25

Check-out: Aug 31

Outpatient visits: Sep 2, 9, 16, 23, Oct 7, 21, Nov 4,